P. Bhaskara Narayana, Director and Chief Financial Officer of Natco Pharma Ltd, is no more. Bhaskara Narayana had joined Natco Pharma in 2000 and played a key role in the company's growth. Earlier, he had served in VST Industries, Ambhuja Petrochemicals, Mahindra & Mahindra and SOL Pharmaceuticals, among others.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
997.6 INR | -2.22% | -2.68% | +22.96% |
05-28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
05-28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.96% | 2.19B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Natco Pharma Limited Announces Demise of P. Bhaskara Narayana, Director and Chief Financial Officer